GM to invest $4 billion in U.S. plants to relocate Blazer production from Mexico and supplement Equinox output amid tariff-driven production rethink.

U.S. equities were mixed and little changed at midday as another key measure of inflation, the Producer Price Index (PPI), came in lower than expected. The S&P 500 and Nasdaq advanced, while the Dow Jones Industrial Average was lower.

– Revumenib was generally well-tolerated in combination with venetoclax/azacitidine in older, newly diagnosed mNPM1 and KMT2Ar AML patients –

BlackRock & Jio Financial JV, Jio BlackRock, secures SEBI approval to act as an investment adviser, deepening its push into India's asset management market.

Salesforce's CRM Agentforce platform, which uses artificial intelligence (AI) to help companies automate tasks and improve customer service, is growing quickly. In just two quarters, Salesforce has signed more than 4,000 paid deals and more than 8,000 total deployments.

Allison to acquire Dana's Off-Highway unit for $2.7B, aiming to expand core tech and boost commercial-duty solutions.

Robinhood's May DARTs increase across equities, options and crypto as product rollouts aim to boost market share and revenues.

ORCL jumps as cloud-fueled AI demand lifts Q4 results and outlook, boosting tech ETFs with top Oracle exposure.

U.S. President Donald Trump expressed frustration on Thursday that oil prices have risen amid supply concerns from potential conflict in the Middle East.

Technical indicators point to more upside for the U.S. benchmark index.

LOS ANGELES , June 12, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ: IOVA). IF YOU SUFFERED A LOSS ON YOUR IOVANCE INVESTMENTS, CLICK HERE BEFORE JULY 14, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

LOS ANGELES, June 12, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming July 1, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Civitas Resources, Inc. (“Civitas” or the “Company”) (NYSE: CIVI) securities between February 27, 2024 and February 24, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR CIVITAS INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.

LOS ANGELES , June 12, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Elevance Health, Inc. ("Elevance" or the "Company") (NYSE: ELV). IF YOU SUFFERED A LOSS ON YOUR ELEVANCE INVESTMENTS, CLICK HERE BEFORE JULY 11, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

LOS ANGELES , June 12, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Napco Security Technologies, Inc. ("Napco" or the "Company") (NASDAQ: NSSC) have opportunity to lead the securities fraud class action lawsuit.

GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT) announces that the reverse stock split will become effective on June 16, 2025, at 12:01 a.m.

NSSC Investors with Losses Encouraged to Contact Hagens Berman Before June 24th Deadline SAN FRANCISCO, CA / ACCESS Newswire / June 12, 2025 / Shares in Napco Security Technologies, Inc. (NASDAQ:NSSC) are trading down nearly 21% year-to-date, as the security technology company continues to face heightened scrutiny as it navigates both legal and operational challenges. Most recently, on May 5, 2025, Napco released its third-quarter financial results for fiscal year 2025, revealing mixed performance metrics amid an ongoing securities class action lawsuit that centers on its distribution practices and sales forecasting.

URGN Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, CA / ACCESS Newswire / June 12, 2025 / A securities class action lawsuit styled Cockrell v. UroGen Pharma Ltd.

NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Gilead Sciences, Inc. ("Gilead" or "the Company") (NASDAQ:GILD). Investors who purchased Gilead securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GILD.

LOS ANGELES , June 12, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Ibotta, Inc. ("Ibotta" or the "Company") (NYSE: IBTA) have opportunity to lead the securities fraud class action lawsuit.

SAN DIEGO--(BUSINESS WIRE)--Today at Cisco Live, Cisco's annual IT and communications conference, Quantum Xchange announced that its Post-Quantum Cryptography (PQC) key management solution, Phio TX®, is now available as a virtual container. The new form factor, Phio TX-EM, is compatible with Cisco networking operating systems IOS XE, IOS XR, as well as the Nexus NX-OS operating system, which will allow Cisco networking users to harden their infrastructure and easily migrate to NIST-standard PQC.